Solid-Nanoemulsion Preconcentrate for Oral Delivery of Paclitaxel: Formulation Design, Biodistribution, and γ Scintigraphy Imaging

Table 2

Stability of radiolabeled complexes of PAC formulations (^99mTc-Intaxel and ^99mTc-PAC loaded solid-nanoemulsion preconcentrate) in saline and plasma at different time intervals.

Time (h)	Radiolabeling efficiency (%)
	Intaxel		PAC loaded solid-; nanoemulsion preconcentrate
	Saline	Plasma	Saline	Plasma
1	95.63±0.24	95.14±0.37	96.85±0.59	96.48±0.26
2	94.72±0.51	94.22±0.41	95.69±0.43	94.91±0.39
4	94.09±0.33	93.56±0.60	95.05±0.72	94.54±1.07
8	93.45±0.86	92.67±1.16	94.17±1.14	93.76±0.96
24	91.86±1.05	90.08±0.93	92.94±0.88	92.11±1.28